Loading...

Neuberger Berman High Yield Strategies Fund Inc.

NHS•AMEX
Financial ServicesAsset Management
$7.33
$-0.01(-0.20%)

Neuberger Berman High Yield Strategies Fund Inc. (NHS) Stock Overview

Explore Neuberger Berman High Yield Strategies Fund Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
86.77%
↑ 86.77%
Profit Growth
$1.14
↑ 920.57%
EPS Growth
$1.14
↑ 814.29%
Operating Margin
87.85%
↓ 100.00%
ROE
17.24%
↑ 920.57%
Dividend Yield
0.00%
↑ 7.29%
Analyst Recommendations data is not available for NHSAnalyst Recommendations details for NHS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.

CEO

Mr. Joseph Vincent Amato

Headquarters

1290 Avenue of the Americas, New York, NY

Founded

2003

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.